XML 114 R97.htm IDEA: XBRL DOCUMENT v3.4.0.3
Pro Forma Information – Viro Acquisition (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Net sales $ 6,730 $ 7,642
Earnings from continuing operations attributable to the Company $ 168 $ 186
Diluted earnings per share from continuing operations $ 1.04 $ 1.12
As Reported    
Net sales $ 6,156 $ 6,784
Earnings from continuing operations attributable to the Company $ 139 $ 187
Diluted earnings per share from continuing operations $ 0.85 $ 1.13
Vitro F&B Adjustments    
Net sales $ 574 $ 858
Earnings from continuing operations attributable to the Company 75 70
Financing Adjustments    
Earnings from continuing operations attributable to the Company $ (46) $ (71)